Invention Grant
- Patent Title: Synthetic route to anti-viral agents
-
Application No.: US16132997Application Date: 2018-09-17
-
Publication No.: US10442792B2Publication Date: 2019-10-15
- Inventor: Russell D. Cink , Kirill A. Lukin , Marvin R. Leanna , Matthew J. Pelc , Timothy B. Towne , Dennie S. Welch , Kenneth M. Engstrom , Matthew M. Ravn , Richard D. Bishop , Gang Zhao , Jianzhang Mei , Jeff M. Kallemeyn , David R. Hill , Michael J. Abrahamson , Westin H. Morrill
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agency: Foley Hoag LLP
- Agent Dana M. Gordon
- Main IPC: C07D403/12
- IPC: C07D403/12 ; C07D405/14 ; C07D241/44 ; C07D405/06 ; C07C271/34 ; C07C43/196 ; C07D487/04 ; C07C269/06 ; C07C41/26 ; C07C67/08 ; C07C68/02 ; C12P1/00 ; C07C211/35 ; C12P41/00 ; C07C69/74 ; C07C269/04
Abstract:
The invention provides methods of synthesizing a viral protease inhibitor in high yield, without using expensive catalysts or challenging reaction conditions.
Public/Granted literature
- US20190084966A1 SYNTHETIC ROUTE TO ANTI-VIRAL AGENTS Public/Granted day:2019-03-21
Information query
